These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3598465)

  • 1. Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells.
    Vlassara H; Valinsky J; Brownlee M; Cerami C; Nishimoto S; Cerami A
    J Exp Med; 1987 Aug; 166(2):539-49. PubMed ID: 3598465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules.
    Vlassara H; Brownlee M; Cerami A
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5588-92. PubMed ID: 2994035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The development of radioimmunoassay and studies of removal system for advanced glycosylation endproduct].
    Kato M
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):152-60. PubMed ID: 2365274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products.
    Radoff S; Vlassara H; Cerami A
    Arch Biochem Biophys; 1988 Jun; 263(2):418-23. PubMed ID: 3377512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor.
    Vlassara H; Moldawer L; Chan B
    J Clin Invest; 1989 Dec; 84(6):1813-20. PubMed ID: 2556447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD47 on experimentally senescent murine RBCs inhibits phagocytosis following Fcgamma receptor-mediated but not scavenger receptor-mediated recognition by macrophages.
    Olsson M; Oldenborg PA
    Blood; 2008 Nov; 112(10):4259-67. PubMed ID: 18779391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.
    Yang Z; Makita Z; Horii Y; Brunelle S; Cerami A; Sehajpal P; Suthanthiran M; Vlassara H
    J Exp Med; 1991 Sep; 174(3):515-24. PubMed ID: 1651976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts.
    Vlassara H; Brownlee M; Cerami A
    J Exp Med; 1984 Jul; 160(1):197-207. PubMed ID: 6736870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of an advanced glycosylation product bound to protein in situ.
    Chang JC; Ulrich PC; Bucala R; Cerami A
    J Biol Chem; 1985 Jul; 260(13):7970-4. PubMed ID: 4008486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against in vivo presence of 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole, a major fluorescent advanced end product generated by nonenzymatic glycosylation.
    Horiuchi S; Shiga M; Araki N; Takata K; Saitoh M; Morino Y
    J Biol Chem; 1988 Dec; 263(35):18821-6. PubMed ID: 3198601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis of phenylhydrazine oxidized and G-6-PD-deficient red blood cells: the role of cell-bound immunoglobulins.
    Horn S; Bashan N; Gopas J
    Blood; 1991 Oct; 78(7):1818-25. PubMed ID: 1912568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent inhibitory effect of CD47 in macrophage uptake of IgG-opsonized murine erythrocytes.
    Olsson M; Nilsson A; Oldenborg PA
    Biochem Biophys Res Commun; 2007 Jan; 352(1):193-7. PubMed ID: 17112468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts.
    Mosser DM; Vlassara H; Edelson PJ; Cerami A
    J Exp Med; 1987 Jan; 165(1):140-5. PubMed ID: 3025330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane glycoprotein modifications of G6PD deficient red blood cells.
    Horn S; Bashan N; Peleg N; Gopas J
    Eur J Clin Invest; 1995 Jan; 25(1):32-8. PubMed ID: 7705384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7.
    Radoff S; Cerami A; Vlassara H
    Diabetes; 1990 Dec; 39(12):1510-8. PubMed ID: 2174009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis of senescent erythrocytes by autologous monocytes: requirement of membrane-specific autologous IgG for immune elimination of aging red blood cells.
    Khansari N; Fudenberg HH
    Cell Immunol; 1983 May; 78(1):114-21. PubMed ID: 6687842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits.
    Palinski W; Koschinsky T; Butler SW; Miller E; Vlassara H; Cerami A; Witztum JL
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):571-82. PubMed ID: 7749871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of advanced glycosylation products in complications of diabetes.
    Cerami A; Vlassara H; Brownlee M
    Diabetes Care; 1988; 11 Suppl 1():73-9. PubMed ID: 3069394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes.
    Bonomini M; Sirolli V; Reale M; Arduini A
    Am J Kidney Dis; 2001 Apr; 37(4):807-14. PubMed ID: 11273881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo.
    Vlassara H; Brownlee M; Cerami A
    Diabetes; 1988 Apr; 37(4):456-61. PubMed ID: 2837419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.